Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › TN › NASHVILLE › NASHVILLE PEDIATRIC PROVIDERS, LLC

NASHVILLE PEDIATRIC PROVIDERS, LLC

NPI: 1992144380 · NASHVILLE, TN 37211 · Pediatric Nurse Practitioner · NPI assigned 06/18/2013

$19.78M
Total Medicaid Paid
921,654
Total Claims
688,503
Beneficiaries
109
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSANFILIPPO, JOSEPH (OWNER)
NPI Enumeration Date06/18/2013

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 80,594 $1.60M
2019 115,639 $2.23M
2020 113,790 $2.18M
2021 147,259 $3.12M
2022 163,046 $3.61M
2023 167,140 $3.86M
2024 134,186 $3.17M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 46,395 41,886 $2.92M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 66,334 60,482 $2.76M
90460 Immunization administration through 18 years of age via any route, first or only component 97,093 57,277 $2.49M
96110 Developmental screening, with scoring and documentation, per standardized instrument 125,603 73,439 $2.09M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 24,504 21,176 $1.67M
96160 112,680 61,814 $1.30M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 20,871 17,483 $1.27M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 16,420 14,588 $1.10M
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 22,109 20,474 $817K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 9,569 8,213 $710K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 8,872 2,527 $378K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 29,985 13,990 $322K
92551 37,112 32,541 $249K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 31,184 28,194 $241K
99177 40,600 35,546 $219K
99401 6,360 5,075 $132K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 4,688 4,016 $120K
99173 26,057 22,567 $98K
90832 Psychotherapy, 30 minutes with patient 2,694 2,293 $69K
69210 2,019 1,809 $68K
90834 Psychotherapy, 45 minutes with patient 1,127 829 $49K
83655 5,662 4,532 $47K
99381 717 622 $46K
D1206 Topical application of fluoride varnish 3,114 3,085 $42K
0002A 1,006 972 $40K
96127 9,663 8,708 $38K
0001A 927 852 $35K
99215 Prolong outpt/office vis 424 383 $35K
92523 287 275 $34K
0072A 874 829 $34K
90670 10,888 9,434 $31K
0071A 735 641 $27K
90480 670 644 $27K
D0190 3,133 3,105 $24K
85018 11,953 9,864 $20K
90677 3,158 2,714 $20K
90651 2,857 2,388 $20K
36415 Collection of venous blood by venipuncture 11,343 9,728 $19K
90461 24,251 19,531 $13K
90680 9,596 8,396 $11K
90686 20,520 17,986 $11K
90671 2,455 1,979 $11K
90698 6,457 5,648 $8K
0112A 205 158 $8K
0004A 159 145 $6K
90697 2,332 1,985 $6K
0111A 160 121 $6K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 85 80 $5K
90619 977 710 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 338 289 $4K
0082A 105 85 $4K
90716 2,405 1,910 $4K
0081A 90 61 $4K
0124A 90 79 $3K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 577 487 $3K
90734 705 605 $3K
90633 6,825 5,606 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 957 911 $3K
36416 2,591 2,031 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2,390 2,230 $3K
99383 31 27 $2K
0154A 62 59 $2K
90688 7,058 6,146 $2K
96161 213 157 $2K
90710 341 313 $2K
90621 196 164 $2K
90707 2,346 1,865 $2K
0164A 45 35 $2K
92508 Group treatment of speech, language, voice, communication, and/or auditory processing disorder 114 48 $2K
87807 211 184 $1K
99384 14 12 $1K
81003 822 733 $1K
90744 3,231 2,754 $1K
99382 14 12 $1K
94664 107 94 $1K
96381 55 39 $906.77
90696 411 368 $857.58
90756 1,573 1,277 $805.66
90656 1,251 1,188 $774.67
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 79 71 $730.13
90620 58 42 $655.63
0083A 16 13 $557.72
81001 259 220 $520.87
86308 135 112 $375.87
90715 242 205 $331.09
94760 660 581 $162.68
94761 285 239 $133.74
90700 666 576 $115.60
90674 136 107 $67.11
90648 582 513 $42.87
90661 233 217 $40.33
91300 2,356 2,067 $40.20
90658 420 414 $29.85
90685 1,154 1,012 $24.78
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 327 287 $14.22
90687 486 432 $11.00
99000 8,041 6,979 $9.14
90381 55 39 $0.27
91312 90 79 $0.20
90657 405 356 $0.09
91307 1,822 1,561 $0.00
91316 62 47 $0.00
91318 13 13 $0.00
91315 62 59 $0.00
91319 12 12 $0.00
91311 458 347 $0.00
91321 167 158 $0.00
91308 293 214 $0.00
91320 28 28 $0.00